Data Mining May Revive Vorapaxar (CME/CE)

(MedPage Today) -- Vorapaxar, a novel antiplatelet inhibitor that didn't fare well in a clinical trial, may have some benefit for patients with a previous myocardial infarction (MI), a prespecified subgroup analysis found. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/08/data-mining-may-revive-vorapaxar-cmece.html